🔎 Trials Near Me

Akèy › Kansè tete negatif triple › Ohio › Cleveland

Etid klinik pou Kansè tete negatif triple nan Cleveland, OH

10 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05867251

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06618287

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06657222

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07029399

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Ap rekriteFaz 1
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05208762

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Ap rekrite
  • MetroHealth, Cleveland
Laj 18 ak plis · Fanm · Mizajou Jun 29, 2026 · NCT05677802

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Ap rekriteFaz 2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06249048

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.